Multi-valent pneumococcal conjugate vaccine for global health: From problem to platform to production

Figures & data

Figure 1. Serotype distributions across various pneumococcal vaccines.

Figure 2. Estimate coverage based on circulating serotypes during the 2017 epidemiological years (in US⁹ and Europe¹⁰) in all age groups. This also would follow in the rest of the world as these stereotypes are present in other parts of the world.

Figure 3. Inventprise solutions has developed a novel design of an integrated platform system controlled with proprietary software – hardware and software for a JIT, local manufacturing solution.

Varghese J, Chochua S, Tran T, Walker H, Li Z, Snippes Vagnone PM, Lynfield R, McGee L, Li Y, Metcalf BJ. Multistate population and whole genome sequence-based strain surveillance of invasive pneumococci recovered in the USA during 2017. Clin Microbiol Infect. 2020 Apr;26(4): 512.e1-512.e10. doi:10.1016/j.cmi.2019.09.008.

 PubMed Web of Science ®Google Scholar

https://atlas.ecdc.europa.eu/public/index.aspx?Dataset=27&HealthTopic=40

 Google Scholar